Quest Diagnostics to Add Roche's Elecsys to Alzheimer's Biomarker Test Portfolio

MT Newswires Live

昨天

Quest Diagnostics (DGX) said Monday it is adding Roche's Elecsys Phospho-Tau Plasma blood test to its AD-Detect portfolio of biomarker tests to detect Alzheimer's disease.

The company said it plans to offer a laboratory test service based on Elecsys in Q4 and incorporate the Roche test into future AD-Detect panels in 2027.

Quest said the US Food and Drug Administration has cleared Roche's Elecsys blood test to assess amyloid pathology associated with Alzheimer's disease across primary and specialty care settings.

Quest also said it will launch its newest AD-Detect lab-developed blood test with low 10% indeterminate rate so more patients can receive an actionable insight.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2661276223"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2661276223\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2661276223?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-24 20:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2661276223","market":"sh","top_or_hot":-1,"title":"Quest Diagnostics to Add Roche's Elecsys to Alzheimer's Biomarker Test Portfolio","media":"MT Newswires Live","content":"<html><body><p> Quest Diagnostics (DGX) said Monday it is adding Roche's Elecsys Phospho-Tau Plasma blood test to its AD-Detect portfolio of biomarker tests to detect Alzheimer's disease.</p><p>The company said it plans to offer a laboratory test service based on Elecsys in Q4 and incorporate the Roche test into future AD-Detect panels in 2027.</p><p>Quest said the US Food and Drug Administration has cleared Roche's Elecsys blood test to assess amyloid pathology associated with Alzheimer's disease across primary and specialty care settings.</p><p>Quest also said it will launch its newest AD-Detect lab-developed blood test with low 10% indeterminate rate so more patients can receive an actionable insight.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Quest Diagnostics to Add Roche's Elecsys to Alzheimer's Biomarker Test Portfolio</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQuest Diagnostics to Add Roche's Elecsys to Alzheimer's Biomarker Test Portfolio\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2026-08-24 20:24</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Quest Diagnostics (DGX) said Monday it is adding Roche's Elecsys Phospho-Tau Plasma blood test to its AD-Detect portfolio of biomarker tests to detect Alzheimer's disease.</p><p>The company said it plans to offer a laboratory test service based on Elecsys in Q4 and incorporate the Roche test into future AD-Detect panels in 2027.</p><p>Quest said the US Food and Drug Administration has cleared Roche's Elecsys blood test to assess amyloid pathology associated with Alzheimer's disease across primary and specialty care settings.</p><p>Quest also said it will launch its newest AD-Detect lab-developed blood test with low 10% indeterminate rate so more patients can receive an actionable insight.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2506951958.HKD","symbol_name":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (HKDHDG) INC","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2661276223","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2661276223","pubTimestamp":1787574276,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Quest Diagnostics  said Monday it is adding Roche's Elecsys Phospho-Tau Plasma blood test to its AD-Detect portfolio of biomarker tests to detect Alzheimer's disease.The company said it plans to offer a laboratory test service based on Elecsys in Q4 and incorporate the Roche test into future AD-Detect panels in 2027.Quest said the US Food and Drug Administration has cleared Roche's Elecsys blood test to assess amyloid pathology associated with Alzheimer's disease across primary and specialty care settings.Quest also said it will launch its newest AD-Detect lab-developed blood test with low 10% indeterminate rate so more patients can receive an actionable insight.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2506951958.HKD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (HKDHDG) INC","LU1854104046.USD":"M&G (LUX) POSITIVE IMPACT \"A\" (USD) ACC","LU1854103824.USD":"M&G (LUX) POSITIVE IMPACT \"A\" (USD) INC","LU2506951875.HKD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (HKDHDG) ACC","BK4567":"ESG概念","BK4196":"保健护理服务","BK4583":"猴痘概念","LU0823417653.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"C\" (USD) ACC","BK4585":"ETF&股票定投概念","LU0950375773.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"C\" (USD) INC A","BK4588":"碎股","DGX":"奎斯特诊疗","LU2506952097.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (USDHDG) ACC","LU2506952170.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (USDHDG) INC","LU0823417737.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"C\" (USD) INC"},"translate_title":"Quest Diagnostics 将罗氏 Elecsys 添加到阿尔茨海默氏症生物标志物测试产品组合中","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DGX":1.5},"content_text":"Quest Diagnostics (DGX) said Monday it is adding Roche's Elecsys Phospho-Tau Plasma blood test to its AD-Detect portfolio of biomarker tests to detect Alzheimer's disease.The company said it plans to offer a laboratory test service based on Elecsys in Q4 and incorporate the Roche test into future AD-Detect panels in 2027.Quest said the US Food and Drug Administration has cleared Roche's Elecsys blood test to assess amyloid pathology associated with Alzheimer's disease across primary and specialty care settings.Quest also said it will launch its newest AD-Detect lab-developed blood test with low 10% indeterminate rate so more patients can receive an actionable insight.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}